SKI Market

A+| A| A-|

Indian Indices

Sensex

77,017.79 -251.61
( -0.33%)

Global Indices

Nasdaq

48,970.60 -549.68
(-1.11%)

Dow Jones

7,222.65 -28.47
(-0.39%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,363.93 -14.87
(-0.14%)

Forex

USD-INR

94.82 -0.13
(-0.14%)

EUR-INR

111.15 0.04
(0.04%)

GBP-INR

128.70 0.21
(0.16%)

JPY-INR

0.60 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ambuja Cements Ltd

Industry : Cement - North India

BSE Code

ISIN Demat

Book Value()

500425

INE079A01024

204.8376183

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMBUJACEM

30.87

110624.06

EPS(TTM)

Face Value()

Div & Yield %

14.42

0.45

Back

ruparel food products ltd

ERIS Lifesciences board approves acquisition of balance 30% stake in Swiss Parenterals

Nov 24,2025

The board of ERIS Lifesciences at its meeting held on 24 November 2025 has approved the acquisition of balance 30% of the total share capital of Swiss Parenterals, a subsidiary of the Company.

Further, the board has approved the issuance of up to 23,06,372 equity shares of the Company on preferential basis to discharge the consideration for acquisition of 30% stake in Swiss Parenterals.

77,017.79 -251.61 ( -0.33%)

48,970.60 -549.68 (-1.11%)

7,222.65 -28.47 (-0.39%)

59,594.47 309.55 (0.52%)

10,363.93 -14.87 (-0.14%)

94.82 -0.13 (-0.14%)

111.15 0.04 (0.04%)

128.70 0.21 (0.16%)

0.60 0.00 (0.59%)